News

We have recently updated our R&D pipeline, adding autoimmune and intractable diseases to our existing pipeline focusing on pulmonary diseases, as well as information on our clinical research in Brazil for sarcopenia.
 
We aim to further expand the potential of our umbilical cord-derived mesenchymal cells to deliver hope for life to patients with limited treatment options, and under our corporate philosophy of “Cords of Life, leading the future ”, we pursue social contributions that only we can make, and contribute to the development of medical care through cutting-edge research and technology.
 
■R&D Pipeline of Huma Lif CORD https://humanlifecord.com/en/business/research/